MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,252,243 | -50.2% | 986,017 | +29.0% | 0.00% | – |
Q2 2023 | $2,515,242 | -67.8% | 764,511 | -59.7% | 0.00% | -100.0% |
Q1 2023 | $7,803,382 | -24.3% | 1,898,633 | +8.0% | 0.00% | 0.0% |
Q4 2022 | $10,301,799 | -4.4% | 1,757,986 | +10.2% | 0.00% | 0.0% |
Q3 2022 | $10,779,000 | +48.3% | 1,594,574 | +1.3% | 0.00% | 0.0% |
Q2 2022 | $7,270,000 | -16.1% | 1,573,704 | -27.5% | 0.00% | 0.0% |
Q1 2022 | $8,663,000 | +13.4% | 2,171,373 | +76.7% | 0.00% | 0.0% |
Q4 2021 | $7,642,000 | +21.3% | 1,228,607 | +84.0% | 0.00% | 0.0% |
Q3 2021 | $6,299,000 | +267.7% | 667,889 | +429.3% | 0.00% | – |
Q2 2021 | $1,713,000 | +704.2% | 126,177 | +853.2% | 0.00% | – |
Q1 2021 | $213,000 | -82.5% | 13,237 | -71.1% | 0.00% | – |
Q4 2020 | $1,217,000 | +359.2% | 45,738 | +220.7% | 0.00% | – |
Q3 2020 | $265,000 | -46.8% | 14,264 | -33.0% | 0.00% | – |
Q2 2020 | $498,000 | +1678.6% | 21,277 | +336.3% | 0.00% | – |
Q1 2020 | $28,000 | -93.6% | 4,877 | -93.6% | 0.00% | – |
Q4 2019 | $436,000 | +1514.8% | 76,048 | +333.5% | 0.00% | – |
Q3 2019 | $27,000 | -95.8% | 17,542 | -88.9% | 0.00% | – |
Q2 2019 | $639,000 | +1675.0% | 157,882 | +2211.3% | 0.00% | – |
Q1 2019 | $36,000 | -54.4% | 6,831 | -64.8% | 0.00% | – |
Q4 2018 | $79,000 | -61.7% | 19,406 | -5.8% | 0.00% | – |
Q3 2018 | $206,000 | -56.7% | 20,595 | -22.8% | 0.00% | – |
Q2 2018 | $476,000 | +23.0% | 26,673 | +8.7% | 0.00% | – |
Q1 2018 | $387,000 | +63.3% | 24,548 | +70.1% | 0.00% | – |
Q4 2017 | $237,000 | -12.5% | 14,429 | -7.9% | 0.00% | – |
Q3 2017 | $271,000 | – | 15,665 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |